Table 1 Clinical characteristics of the patients
Factor | TCGA LUAD Training | TCGA LUAD Validation | TCGA COAD Training | TCGA COAD Validation |
|---|---|---|---|---|
Num. of patients | 328 | 167 | 286 | 141 |
Age, years, mean (SD) | 65.8 (10.2) | 64.5 (9.6) | 66.6 (12.8) | 66.4 (13.5) |
Median survivor follow-up, days | 506.5 | 218.0 | 716.5 | 730.0 |
Female, num. (%) | 169 (51.5) | 97 (58.1) | 151 (52.8) | 52 (36.9) |
Stage I, num. (%) | 176 (53.7) | 90 (54.0) | 50 (17.5) | 22 (15.6) |
Stage II, num. (%) | 77 (23.5) | 39 (23.4) | 101 (35.3) | 62 (44.0) |
Stage III, num. (%) | 49 (14.9) | 31 (18.6) | 75 (26.2) | 44 (31.2) |
Stage IV, num. (%) | 21 (6.4) | 5 (3.0) | 50 (17.5) | 12 (8.5) |